Inferra AI / Company / PRVA

Privia Health Group, Inc.

PRVA · Health Care

Last earnings Aug 6, 2026

AI analysis

Q2 2025 · reported Aug 7, 2025

Based on: Earnings release + parent 8-K + 10-Q — transcript not held

No extracted figures held

The event-summary record for this company carries no extracted figures, so the brief and charts cannot be drawn yet. The summary below and the held documents are the record for this event.

Guidance · company-stated

Direction: Raised

Revenue

“htm EX-99.1 Document Exhibit 99.1 Privia Health Reports Second Quarter 2025 Financial Results Very Strong First Half Performance Across All Key Operating and Financial Metrics Implemented Providers +13.8% and Practice Collections +18.5% compared to 2Q 24 Guidance Raised to Above High End of Range for Practice Collections, GAAP Revenue, Platform Contribution and Adjusted EBITDA c ARLINGTON, VA August 7, 2025 Privia Health Group, Inc.”

Margin

“Key Operating and Non-GAAP Financial Metrics b d e For the Six Months Ended June 30, ($ in millions) 2025 2024 Change (%) Practice Collections $ 1,661.5 $ 1,435.7 15.7 % Care Margin b d $ 220.4 $ 194.7 13.2 % Platform Contribution b d $ 109.2 $ 92.1 18.5 % Adjusted EBITDA b d e $ 55.9 $ 41.9 33.3 % Updated FY 25 Guidance c d e f Privia Health raised its full-year 2025 outlook as follows FY 2024 Initial FY 2025 Guidance at 2.27.25 c Updated FY 2025 Guidance at 8.7.”

Classified from the release's primary full-year outlook statement.

Next earningsNo verified date on fileNo date is estimated or imported

Capital allocation

Second Quarter 2025 highlights include Continued strength in same-store growth and new provider additions, +13.8% versus 2Q 24 Practice Collections of $862.9 million, +18.5% versus 2Q 24 Adjusted EBITDA b d e of $29.0 million, +31.6% versus 2Q 24 Strong sales and business development pipeline and Cash of $390.1 million and no debt following $95 million deployed for IMS transaction in Arizona.

Debt On November 16, 2023, Privia Health Group, Inc.

General educational research only — not investment advice.Every figure is as stated in the held documents; values marked “computed from stated figures” are arithmetic on those stated figures. Guidance shown is the company’s own stated guidance. No price targets, no recommendations, no consensus estimates.

Event summary

Reconciliations of non-GAAP adjusted net income and other non-GAAP financial measures are presented in tables near the end of this press release

Based on: Earnings release + parent 8-K + 10-Q — transcript not held

Guidance & outlook

Direction: Raised

Revenue: “htm EX-99.1 Document Exhibit 99.1 Privia Health Reports Second Quarter 2025 Financial Results Very Strong First Half Performance Across All Key Operating and Financial Metrics Implemented Providers +13.8% and Practice Collections +18.5% compared to 2Q 24 Guidance Raised to Above High End of Range for Practice Collections, GAAP Revenue, Platform Contribution and Adjusted EBITDA c ARLINGTON, VA August 7, 2025 Privia Health Group, Inc.”

Margin: “Key Operating and Non-GAAP Financial Metrics b d e For the Six Months Ended June 30, ($ in millions) 2025 2024 Change (%) Practice Collections $ 1,661.5 $ 1,435.7 15.7 % Care Margin b d $ 220.4 $ 194.7 13.2 % Platform Contribution b d $ 109.2 $ 92.1 18.5 % Adjusted EBITDA b d e $ 55.9 $ 41.9 33.3 % Updated FY 25 Guidance c d e f Privia Health raised its full-year 2025 outlook as follows FY 2024 Initial FY 2025 Guidance at 2.27.25 c Updated FY 2025 Guidance at 8.7.”

Revenue — Raised (“Raised”)
“htm EX-99.1 Document Exhibit 99.1 Privia Health Reports Second Quarter 2025 Financial Results Very Strong First Half Performance Across All Key Operating and Financial Metrics Implemented Providers +13.8% and Practice Collections +18.5% compared to 2Q 24 Guidance Raised to Above High End of Range for Practice Collections, GAAP Revenue, Platform Contribution and Adjusted EBITDA c ARLINGTON, VA August 7, 2025 Privia Health Group, Inc.”

Margin — Raised (“raised”)
“Key Operating and Non-GAAP Financial Metrics b d e For the Six Months Ended June 30, ($ in millions) 2025 2024 Change (%) Practice Collections $ 1,661.5 $ 1,435.7 15.7 % Care Margin b d $ 220.4 $ 194.7 13.2 % Platform Contribution b d $ 109.2 $ 92.1 18.5 % Adjusted EBITDA b d e $ 55.9 $ 41.9 33.3 % Updated FY 25 Guidance c d e f Privia Health raised its full-year 2025 outlook as follows FY 2024 Initial FY 2025 Guidance at 2.27.25 c Updated FY 2025 Guidance at 8.7.”

Classified from the release's primary full-year outlook statement.

Capital allocation

Second Quarter 2025 highlights include Continued strength in same-store growth and new provider additions, +13.8% versus 2Q 24 Practice Collections of $862.9 million, +18.5% versus 2Q 24 Adjusted EBITDA b d e of $29.0 million, +31.6% versus 2Q 24 Strong sales and business development pipeline and Cash of $390.1 million and no debt following $95 million deployed for IMS transaction in Arizona.

SEC original ↗Privia Health Group, Inc. — Earnings release (8-K exhibit)EX-99Aug 7, 2025

Debt On November 16, 2023, Privia Health Group, Inc.

SEC original ↗Privia Health Group, Inc. — 10-Q Quarterly report10-QAug 6, 2026

, and Privia Health, LLC, as borrower, (collectively, the Privia Parties ) entered into a credit agreement (the Revolving Credit Agreement ) with Wells Fargo Bank, National Association, as issuing lender, and certain other lenders, pursuant to which the Privia Parties established a $ 125 million five-year senior secured revolving credit facility (the Revolving Credit Facility ).

SEC original ↗Privia Health Group, Inc. — 10-Q Quarterly report10-QAug 6, 2026

The Revolving Credit Agreement includes a commitment fee on the unused Revolving Credit Facility that ranges from 0.20 % to 0.30 % ( 0.20 % per annum at year end) depending on the consolidated leverage ratio.

SEC original ↗Privia Health Group, Inc. — 10-Q Quarterly report10-QAug 6, 2026

The facility generally may be used for capital expenditures, expenses related to transactions and general corporate purposes.

SEC original ↗Privia Health Group, Inc. — 10-Q Quarterly report10-QAug 6, 2026

As of June 30, 2026, no amounts were outstanding under the Revolving Credit Facility.

SEC original ↗Privia Health Group, Inc. — 10-Q Quarterly report10-QAug 6, 2026

Strategy & priorities

Forward-looking statements can be identified by words such as aims, anticipates, assumes, believes, estimates, expects, forecasts, future, intends, likely, may, outlook, plans, potential, projects, seeks, strategy, targets, trends, will, would, could, should, and variations of such terms and similar expressions and references to guidance, although some forward-looking statements may be expressed differently.

SEC original ↗Privia Health Group, Inc. — Earnings release (8-K exhibit)EX-99Aug 7, 2025

These forward-looking statements, which are subject to risks, uncertainties and assumptions about us, may include projections of our future financial performance, our anticipated growth strategies and anticipated trends in our business.

SEC original ↗Privia Health Group, Inc. — 10-Q Quarterly report10-QAug 6, 2026

On March 2, 2023, the Company entered into a strategic alignment agreement (the Equity Alignment Agreement ) with ChoiceHealth, Inc.

SEC original ↗Privia Health Group, Inc. — 10-Q Quarterly report10-QAug 6, 2026

Risks & headwinds

Should known or unknown risks or uncertainties materialize, or should underlying assumptions prove inaccurate, actual results may differ materially from past results and those anticipated, estimated or projected.

SEC original ↗Privia Health Group, Inc. — Earnings release (8-K exhibit)EX-99Aug 7, 2025

Legal Proceedings 30 Item 1A.

SEC original ↗Privia Health Group, Inc. — 10-Q Quarterly report10-QAug 6, 2026

These forward-looking statements, which are subject to risks, uncertainties and assumptions about us, may include projections of our future financial performance, our anticipated growth strategies and anticipated trends in our business.

SEC original ↗Privia Health Group, Inc. — 10-Q Quarterly report10-QAug 6, 2026

We are currently involved in, and may in the future become involved in, legal proceedings, claims, investigations and regulatory inquiries in the ordinary course of our business, including medical malpractice claims.

SEC original ↗Privia Health Group, Inc. — 10-Q Quarterly report10-QAug 6, 2026

Although the results of these legal proceedings, claims, investigations and inquiries cannot be predicted with certainty, we do not believe that the final outcome of any matters that we are currently involved in are reasonably likely to have a material adverse effect on our business, financial condition or results of operations.

SEC original ↗Privia Health Group, Inc. — 10-Q Quarterly report10-QAug 6, 2026

Competitors

Competitors & peers

Same GICS sector — classification peers, not declared competitors

Documents

Filings

34 documents

Earnings releases

9 documents

Presentations

0 documents

No presentations for Privia Health Group, Inc. are held in this edition of the library.

Transcripts

0 documents

No transcripts for Privia Health Group, Inc. are held in this edition of the library.

See also the earnings calendar for every tracked company’s next earnings date.